RekrutujeFaza III
A Study of Precemtabart Tocentecan With or Without Bevacizumab Compared to Trifluridine/Tipiracil Plus Bevacizumab in Participants With Previously Treated Metastatic Colorectal…
Miasta: Gdańsk, Kraków, ŁódźWiek: od 18 latSponsor: Merck Healthcare KGaA
W Polsce: Wkrótce rekrutacjaNa świecie: RekrutujeFaza I/II
Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors
Miasta: Gdańsk, Poznań, Warszawa, ŁódźWiek: od 18 latSponsor: Revolution Medicines Inc.
RekrutujeFaza III
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
Miasta: Gdańsk, Gliwice, Olsztyn, Opole i 4 inne miastaWiek: od 18 latSponsor: Summit Therapeutics Inc.
RekrutujeFaza II/III
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously…
Miasta: Brzozów, Gdańsk, Gliwice, Jelenia Góra i 5 innych miastWiek: od 18 latSponsor: Bristol-Myers Squibb Services Unlimited Company
RekrutujeFaza III
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received…
Miasta: Biała Podlaska, Białystok, Brzozów, Gdańsk i 5 innych miastWiek: od 18 latSponsor: Janssen Cilag International
RekrutujeFaza III
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or…
Miasta: Biała Podlaska, Białystok, Brzozów, Gdańsk i 5 innych miastWiek: od 18 latSponsor: Janssen Cilag International
RekrutujeFaza I
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
Miasta: Bydgoszcz, Gdańsk, Otwock, Poznań i 1 inne miastoWiek: od 18 latSponsor: Exelixis Inc.
RekrutujeFaza I
A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients with Metastatic Colorectal Cancer (INTRINSIC)
Miasta: Gdańsk, Kraków, Poznań, WarszawaWiek: od 18 latSponsor: F. Hoffmann-La Roche AG
Rekrutuje
Stereotactic Body Radiotherapy in Patients With Rare Oligometastatic Cancers (OligoRARE)
Miasta: Gdańsk, WarszawaWiek: od 18 latSponsor: European Organisation for Research and Treatment of Cancer…
W Polsce: Rekrutacja zakończonaNa świecie: RekrutujeFaza II
A Phase 2 Study of T-DXd in Patients With Selected HER2 Expressing Tumors
Miasta: Bydgoszcz, Gdańsk, Kraków, Poznań i 1 inne miastoWiek: od 18 latSponsor: AstraZeneca AB